|

Cataract surgery more than meets front of the
eye
By
Roibeard O'hÉineacháin
NICE - Anterior segment surgeons should pay more attention to the
posterior part of the eye, Philippe Sourdille MD told a clinical
research sysmposium at the XX ESCRS Congress.
While most of the action in cataract surgery takes place in the
anterior segment of the eye, the procedure can nonetheless have
deleterious effects on the posterior segment, including the onset
of macular oedema and accelerated macular degeneration, he noted.
Cataract surgery has the potential to induce changes in the eye
which can have longstanding consequences, most of which occur in
the posterior segment.
The invasive nature of the procedure means surgeons should consider
the risk of altering the blood-ocular barriers in some way, which
in some patients will lead to macular oedema, he noted.
Furthermore, unless special care is taken, the surgery can worsen
pre-existing conditions such as age-related macular degeneration
(AMD) and predisposing conditions (drusen) and diabetic retinopathy,
he added.
One of the underestimated sequelae of cataract surgery is postoperative
hypotony. While the condition is infrequent and generally short-lived,
long-lasting hypotony could be responsible for macular folds.
It is always the result of high pressure changes during the operation
which in turn causes an unnoticed cyclodialysis cleft, he noted.
"I think we should be aware especially in these times when
we use both high quantities of serum in the anterior chamber and
high vacuum that we may be more prone than before to inducing potentially
clinically important pressure changes during the operation,"
Dr Sourdille said.
The treatment involves a transcleral suture of the ciliary body,
a procedure which most ophthalmic surgeons can accomplish in a few
minutes using topical anaesthesia.
In virtually all patients it results in total anatomical and functional
resolution of the condition.
Retinal changes arising from the use of ocular hypotensive medication
(Latanoprost) in the treatment of glaucoma and ocular hypertension
is another factor cataract surgeons increasingly need to take into
account.
Blood-retinal barrier ruptures occur in up to 6% of patients receiving
such agents.
Several reports in the literature have shown that they occur more
frequently in aphakic eyes than phakic eyes. Cataract might therefore
also increase the risk.
"Blood-retinal barrier ruptures resolve after treatment interruption.
It is therefore wise to do some laser flare cell measurements preoperatively
in patients receiving long-term hypotensive therapy to detect flare
elevation.
"Treatment should be stopped two weeks prior to the operation
and patients should receive NSAIDs postoperatively. Such cases require
a careful macular follow-up and patients should be given all the
necessary information about their changing drug regimen," Dr
Sourdille explained.
While most patients with AMD obtain an improvement in vision from
cataract surgery, the procedure can actually increase the risk for
the condition in some patients.
Furthermore, the increased light that reaches the retina may accelerate
the disease, even in eyes with IOLs which have UV filters.
"This increased rate of macular degeneration together with
an increased number of cataract operations might become a public
health problem," he noted.
Patients at risk from developing AMD after cataract procedures generally
have other predisposing factors, including drusen, increased autofluorescence
of the retina and pigment accumulation.
There are also iatrogenic factors associated with the surgery itself
that can increase the risk. They include surgically induced macular
changes and CMO.
With regard to the IOLs themselves, additional filters may provide
more protection against the acceleration of AMD.
In a study done by Kensaku Miyake MD in Japan, patients with yellow
filters had significantly less AMD during a nine-year follow-up
than those with no filters or those with conventional blue filters.
In patients with diabetic retinopathy there is the danger that the
condition may change from the non-proliferative form to the proliferative
form of the disease.
The risk is highest in insulin-treated patients and in those who
have higher immunoglobulin levels and when CMO is present preoperatively.
Patients with diabetic retinopathy should therefore undergo special
examinations such as preoperative angiography, laser treatment if
needed and, if possible, laser flare cell measurements before the
cataract operation.
"Retinal diabetic retinopathy and cataract means a combined
operation. We should remember that combined operations require combined
surgeons who are as skilled with vitreoretinal surgery as they are
with cataract operations," he said.
A one-step operation - vitreoretinal and cataract - is safer than
two successive procedures which increase the risk of retinal complications
Ophthalmologists currently have many ways available to them to monitor
changes in the retina after cataract surgery. They include laser
flare cell measurement, fluorescein angiography and nerve fibre
analysers.
One of the more recently available technologies for the early detection
of CMO is optical computerised tomography (OCT), which provides
a reproducible and non-invasive way to measure changes in macular
thickness.
In a study involving a consecutive series of cataract patients,
Dr Sourdille and his associates were able to identify macular thickness
changes, earlier with OCT than they were with fluorescein angiography.
OCT detected changes from a normal thickness of 160 microns to 400
microns and more. Such changes can give rise to CMO, he noted.
"This is a very elegant and clinical way to follow any modification
of the blood-retinal barrier and of the macular thicknesses after
operation.
"We were surprised that even after uncomplicated surgery, we
still had 20% with macular thickness changes that correlate with
published angiographic CMO levels after cataract operation,"
Dr Sourdille said.
Top |